Literature DB >> 29769281

Comparison of the Xpert Flu/RSV XC and Xpress Flu/RSV Assays.

Elena B Popowitch1, Melissa B Miller2.   

Abstract

Molecular diagnostics for influenza and respiratory syncytial virus (RSV) have become commonplace, and various tests and systems have been cleared by the FDA for use in the United States. We performed a retrospective study to compare the Cepheid Xpress Flu/RSV assay with the Xpert Flu/RSV XC assay, using laboratory-developed tests (LDTs) as the reference method. The Xpress assay was 100% accurate compared to LDTs, whereas the Xpert Flu/RSV XC assay was 96.0% accurate. The Xpress test was determined to be faster and more sensitive than the XC assay.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Cepheid; Xpert; influenza; molecular diagnostics; respiratory syncytial virus

Mesh：

Year:  2018        PMID： 29769281      PMCID： PMC6062788          DOI： 10.1128/JCM.00278-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  Performance Characteristics of Xpert Flu/RSV XC Assay.

Authors:  Elena B Popowitch; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

2.  Simultaneous detection of influenza viruses A and B using real-time quantitative PCR.

Authors:  L J van Elden; M Nijhuis; P Schipper; R Schuurman; A M van Loon
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 3.  Respiratory syncytial virus infection in adult populations.

Authors:  Edward E Walsh; Ann R Falsey
Journal:  Infect Disord Drug Targets       Date:  2012-04

4.  Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults.

Authors:  L J R van Elden; A M van Loon; A van der Beek; K A W Hendriksen; A I M Hoepelman; M G J van Kraaij; P Schipper; M Nijhuis
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

5.  Respiratory Syncytial Virus Seasonality - United States, 2014-2017.

Authors:  Erica Billig Rose; Alexandra Wheatley; Gayle Langley; Susan Gerber; Amber Haynes
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-19       Impact factor: 17.586
  5 in total
  2 in total

Review 1.  Cost-Effective Respiratory Virus Testing.

Authors:  B A Pinsky; R T Hayden
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

2.  Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults.

Authors:  Roy P Zuurbier; Koos Korsten; Theo J M Verheij; Chris Butler; Niels Adriaenssens; Samuel Coenen; Olivier Gruselle; Valerie Vantomme; Marlies A van Houten; Louis J Bont; Joanne G Wildenbeest
Journal:  J Infect Dis       Date:  2022-08-12       Impact factor: 7.759
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.